BIOPOL CHEMICALS LIMITED
Biopol Chemicals maintains a debt-to-equity ratio of 0.57 and a current ratio of 1.81, indicating moderate leverage and adequate short-term liquidity to cover its obligations. However, the company reported negative operating cash flow of INR 23.37 million, which raises concerns about its ability to fund operations from core business activities. Free cash flow of INR 43.90 million suggests some capacity to reinvest or return capital to shareholders, but the negative operating cash flow remains a red flag. The company's profitability metrics show a return on equity (ROE) of 32.07% and a return on assets (ROA) of 13.8%, both exceeding the typical thresholds for the specialty chemicals industry. These figures suggest strong returns relative to equity and asset base. However, the operating margin of 13.2% (calculated from operating income of INR 64.63 million on revenue of INR 491.28 million) is slightly below the industry median of 15.5%, indicating potential inefficiencies or pricing pressures. Biopol Chemicals' revenue is concentrated across four product categories: silicones (40 products), emulsifiers (5 products), biochemicals (15 products), and polyelectrolytes (6 products). The company does not disclose geographic revenue breakdowns, but as an India-based firm, it is likely exposed to domestic market conditions and regulatory changes. The lack of geographic diversification could increase vulnerability to regional economic downturns or policy shifts. The company's growth trajectory is uncertain, as no specific revenue growth rates or outlooks are provided in the input data. However, the negative operating cash flow and moderate capital expenditure of INR 245,000 suggest limited reinvestment in growth initiatives. The absence of a clear growth strategy or expansion plans in the input data raises questions about the company's long-term scalability. The risk assessment highlights medium liquidity risk due to negative net cash after subtracting total debt, and low dilution risk based on the absence of dilutive instruments or recent equity issuances. The company's capital structure is relatively conservative, with long-term debt of INR 76.85 million and total equity of INR 135.45 million, but the negative operating cash flow could pressure liquidity if not addressed. Recent events or filings are not detailed in the input data, but the company's technical consultancy services and product portfolio suggest a focus on value-added solutions for customers in textiles, agriculture, and industrial applications. The lack of recent events or transcripts limits visibility into management's strategic direction or operational updates.
Business. Biopol Chemicals Limited is an India-based company engaged in the trading, manufacturing, and distribution of specialty chemicals, including silicones, emulsifiers, biochemicals, and polyelectrolytes, with applications in textiles, home care, agriculture, and industrial chemicals.
Classification. Biopol Chemicals is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.
- Biopol Chemicals has strong ROE and ROA but operates with a negative operating cash flow, signaling potential liquidity constraints.
- The company's product portfolio is concentrated in four categories, with no geographic diversification disclosed.
- Free cash flow is positive, but capital expenditure is minimal, suggesting limited reinvestment in growth.
- The debt-to-equity ratio is moderate, but the negative net cash position raises liquidity concerns.
- The company's risk profile is characterized by medium liquidity risk and low dilution risk.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.